Normal view MARC view ISBD view

Optimal parameters for near infrared fluorescence imaging of amyloid plaques in Alzheimer's disease mouse models. [electronic resource]

By:

Raymond, S B

Contributor(s):

Producer: 20100218Description: 6201-16 p. digitalISSN:

1361-6560

Subject(s):

Online resources:

Available from publisher's website

In: Physics in medicine and biology vol. 54

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article; Research Support, N.I.H., Extramural

There are no comments on this title.

to post a comment.

Back to results

21 A comparison of chemoembolization endpoints using angiographic versus transcatheter intraarterial perfusion/MR imaging monitoring.
by Lewandowski, Robert J
22 Radiation dose limits and liver toxicities resulting from multiple yttrium-90 radioembolization treatments for hepatocellular carcinoma.
by Young, Joseph Y
23 Safety and efficacy of 90Y radiotherapy for hepatocellular carcinoma with and without portal vein thrombosis.
by Kulik, Laura M
24 90Y radioembolization of metastatic breast cancer to the liver: toxicity, imaging response, survival.
by Bangash, Affaan K
25 Incidence of radiation pneumonitis after hepatic intra-arterial radiotherapy with yttrium-90 microspheres assuming uniform lung distribution.
by Salem, Riad
26 Radioembolization with 90Y microspheres: angiographic and technical considerations.
by Lewandowski, Robert J
27 Radiation segmentectomy: a novel approach to increase safety and efficacy of radioembolization.
by Riaz, Ahsun
28 Multimodality imaging following 90Y radioembolization: a comprehensive review and pictorial essay.
by Atassi, Bassel
29 Radioembolization for neuroendocrine liver metastases: safety, imaging, and long-term outcomes.
by Memon, Khairuddin
30 Radioembolization for hepatocellular carcinoma using Yttrium-90 microspheres: a comprehensive report of long-term outcomes.
by Salem, Riad
31 Twelve-year experience of radioembolization for colorectal hepatic metastases in 214 patients: survival by era and chemotherapy.
by Lewandowski, Robert J
32 Unresectable chemorefractory liver metastases: radioembolization with 90Y microspheres--safety, efficacy, and survival.
by Sato, Kent T
33 Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience.
by Salem, Riad
34 Radioembolization results in longer time-to-progression and reduced toxicity compared with chemoembolization in patients with hepatocellular carcinoma.
by Salem, Riad